Abstract
GERSTMANN–Sträussler syndrome is a rare familial neuro-degenerative condition that is vertically transmitted, in an apparently autosomal dominant way1. It can also be horizontally transmitted to non-human primates and rodents through intracerebral inoculation of brain homogenates from patients with the disease2–8. The exact incidence of the syndrome is unknown but is estimated to be between one and ten per hundred million. Patients initially suffer from ataxia or dementia and deteriorate until they die, in one to ten years. Protease-resistant prion protein (PrP) and PrP-immunoreactive amyloid plaques with characteristic morphology accumulate in the brains of these patients9–11. Current diagnostic criteria for Gerstmann–Sträussler syndrome incorporate clinical and neuropathological features, as animal transmission studies can be unreliable8,12. PrP is implicated in the pathogenesis and transmission of the condition and in scrapie, an equivalent animal disease13–17. It was discovered by enriching scrapie-infected hamster brain fractions for infectivity18,19. Because jthere is compelling evidence that the scrapie isoform of PrP is a necessary component of the infectious particle15,16, it seemed possible that the PrP gene on the short arm of human chromosome 20 (ref. 20) in Gerstmann–Sträussler syndrome might be abnormal. We show here that PrP codon 102 is linked to the putative gene for the syndrome in two pedigrees, providing the best evidence to date that this familial condition is inherited despite also being infectious, and that substitution of leucine for proline at PrP codon 102 may lead to the development of Gerstmann–Sträussler syndrome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gerstmann, J., Sträussler, E. & Scheinker, I. Z. Neurol. 154, 736–762 (1936).
Tateishi, J., Ohta, M., Koga, M., Sato, Y. & Kuroiwa, Y. Ann. Neurol. 5, 581–584 (1979).
Tateishi, J., Koga, M., Sato, Y. & Mori, R. Ann. Neurol. 7, 390–391 (1980).
Masters, C. L., Gajdusek, D. C. & Gibbs, C. J. Jr Brain 104, 559–588 (1981).
Tateishi, J., Sato, Y. & Boellaard, J. W. Acta neuropath. 64, 85–88 (1984).
Baker, H. F., Ridley, R. M. & Crow, T. J. Br. med. J. 291, 299–302 (1985).
Tateishi, J., Kitamoto, T., Hashiguchi, H. & Shii, H. Ann. Neurol. 24, 35–40 (1988).
Masters, C. L., Gajdusek, D. C. & Gibbs, C. J. Jr Brain 104, 535–558 (1981).
Bockman, J. M., Prusiner, S. B., Tateishi, J. & Kingsbury, D. T. Ann. Neurol. 21, 589–595 (1987).
Kitamoto, T., Ogomori, K., Tateishi, J. & Prusiner, S. B. Lab. Invest. 57, 230–236 (1987).
Roberts, G. W. et al. New Engl. J. Med. 315, 1231–1233 (1986).
Gibbs, C. J. Jr, Gajdusek, D. C. & Amyx, H. in Slow Transmissible Diseases of the Nervous System Vol. 2, 87–110 (Academic, New York, 1979).
Carlson, G. A. et al. Cell 46, 503–511 (1986).
Westaway, D. et al. Cell 51, 651–662 (1987).
Prusiner, S. B. New Engl. J. Med. 317, 1571–1581 (1987).
Gabizon, R., McKinley, M. P., Groth, D. F. & Prusiner, S. B. Proc. natn. Acad. Sci. U.S.A. 85, 6617–6621 (1988).
Hunter, N., Hope, J., McConnell, I. & Dickinson, A. G. J. gen. Virol. 68, 2711–2716 (1987).
Prusiner, S. B. et al. Biochemistry 21, 6942–6950 (1982).
Bolton, D. C., McKinley, M. P. & Prusiner, S. B. Science 218, 1309–1311 (1982).
Sparkes, R. S. et al. Proc. natn. Acad. Sci. U.S.A. 83, 7368–7362 (1986).
Kretzschmar, H. A. et al. DNA 5, 315–324 (1986).
Wu, Y. et al. Nucleic Acids Res. 15, 3191 (1987).
Ott, J. Analysis of Human Genetic Linkage (Johns Hopkins University Press, Baltimore, 1985).
Barker, D., Schafer, M. & White, R. Cell. 36, 131–138 (1984).
Basler, et al. Cell 46, 417–428 (1986).
Oesch, B. et al. Cell 40, 735–746 (1985).
Locht, C., Chesebro, B., Race, R. & Keith, M. Proc. natn. Acad. Sci. U.S.A. 83, 6372–6376 (1986).
Liao, Y-C. Lab. Invest. 57, 370–374 (1987).
Lowenstein, D. H., Butler, D., McKinley, M. P. & Prusiner, S. B. J. Cell Biol. 107, 136 (1988).
Bazan, J. F., Fletterick, R. J., McKinley, M. P. & Prusiner, S. B. Protein Engng 1, 125–135 (1987).
Seeburg, P. H., Colby, W. W., Capon, D. J., Goeddel, D. V. & Levinson, A. D. Nature 312, 71–75 (1984).
de Vos, A. M. et al. Science 239, 888–893 (1988).
Bunn, H. F. & Forget, B. G. Hemoglobin: Molecular, Genetic and Clinical Aspects, 595–622 (Saunders, Philadelphia, 1986).
Goelz, S. E., Hamilton, S. R. & Vogelstein, B. Biochem. biophys. Res. Commun. 130, 118–126 (1985).
Maxam, A. M. & Gilbert, W. Proc. natn. Acad. Sci. U.S.A. 74, 560–564 (1977).
Biggin, M. D., Gibson, T. J. & Hong, G. F. Proc. natn. Acad. Sci. U.S.A. 80, 3963–3965 (1983).
Rosenthal, N. P., Keesey, J., Crandall, B. & Brown, W. J. Arch. Neurol. 33, 252–259 (1976).
Adam, J., Crow, T. J., Duchen, L. W., Scaravilli, F. & Spokes, E. J. Neurol. Neurosurg. Psychiat. 45, 37–45 (1982).
Saiki, R. K. et al. Science 239, 487–491 (1988).
Owen, F. et al. Lancet i, 51–52 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hsiao, K., Baker, H., Crow, T. et al. Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome. Nature 338, 342–345 (1989). https://doi.org/10.1038/338342a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/338342a0
This article is cited by
-
First familial cases of P102L Gerstmann–Sträussler–Scheinker syndrome in South Korea: diffusion-weighted imaging might reflect intrafamilial phenotypic variability
Neurological Sciences (2022)
-
The G127V variant of the prion protein interferes with dimer formation in vitro but not in cellulo
Scientific Reports (2021)
-
Environmental and host factors that contribute to prion strain evolution
Acta Neuropathologica (2021)
-
Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification
Acta Neuropathologica (2021)
-
Relevance of biomarkers across different neurodegenerative diseases
Alzheimer's Research & Therapy (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.